Recent flow cytometry analysis has confirmed this association between MMR and PTPRG-restored expression in CML patients after TKI-treatment (Figure 2; Table 2; Table 3) (Drube et al., 2018; Ismail et al., 2021). This evidence concerns the gene PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive.